Structure

Physi-Chem Properties

Molecular Weight:  256.09
Volume:  249.747
LogP:  0.203
LogD:  0.967
LogS:  -1.647
# Rotatable Bonds:  6
TPSA:  85.22
# H-Bond Aceptor:  6
# H-Bond Donor:  2
# Rings:  1
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.753
Synthetic Accessibility Score:  2.651
Fsp3:  0.417
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.663
MDCK Permeability:  5.7970806665252894e-05
Pgp-inhibitor:  0.002
Pgp-substrate:  0.015
Human Intestinal Absorption (HIA):  0.009
20% Bioavailability (F20%):  0.009
30% Bioavailability (F30%):  0.054

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.78
Plasma Protein Binding (PPB):  24.511690139770508%
Volume Distribution (VD):  0.842
Pgp-substrate:  52.634334564208984%

ADMET: Metabolism

CYP1A2-inhibitor:  0.047
CYP1A2-substrate:  0.879
CYP2C19-inhibitor:  0.025
CYP2C19-substrate:  0.885
CYP2C9-inhibitor:  0.016
CYP2C9-substrate:  0.628
CYP2D6-inhibitor:  0.004
CYP2D6-substrate:  0.465
CYP3A4-inhibitor:  0.037
CYP3A4-substrate:  0.643

ADMET: Excretion

Clearance (CL):  9.326
Half-life (T1/2):  0.9

ADMET: Toxicity

hERG Blockers:  0.009
Human Hepatotoxicity (H-HT):  0.327
Drug-inuced Liver Injury (DILI):  0.234
AMES Toxicity:  0.015
Rat Oral Acute Toxicity:  0.027
Maximum Recommended Daily Dose:  0.1
Skin Sensitization:  0.18
Carcinogencity:  0.028
Eye Corrosion:  0.005
Eye Irritation:  0.092
Respiratory Toxicity:  0.059

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC203351

Natural Product ID:  NPC203351
Common Name*:   Berfussinol
IUPAC Name:   methyl (2S)-3-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)propanoate
Synonyms:   Berfussinol
Standard InCHIKey:  YGUTYWCRKWUWOT-MRVPVSSYSA-N
Standard InCHI:  InChI=1S/C12H16O6/c1-16-9-4-7(5-10(17-2)11(9)14)8(6-13)12(15)18-3/h4-5,8,13-14H,6H2,1-3H3/t8-/m1/s1
SMILES:  COC(=O)[C@@H](c1cc(OC)c(c(c1)OC)O)CO
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1760595
PubChem CID:   54586911
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000134] Phenols
        • [CHEMONTID:0000190] Methoxyphenols

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO4001 Berberis koreana Species Berberidaceae Eukaryota n.a. n.a. n.a. PMID[19813743]
NPO4001 Berberis koreana Species Berberidaceae Eukaryota trunk Jeju island, Korea 2005-Dec PMID[21420296]
NPO4001 Berberis koreana Species Berberidaceae Eukaryota n.a. n.a. n.a. PMID[21420296]
NPO4001 Berberis koreana Species Berberidaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell Line A549 Homo sapiens IC50 > 30000.0 nM PMID[529383]
NPT147 Cell Line SK-MEL-2 Homo sapiens IC50 = 27170.0 nM PMID[529383]
NPT574 Cell Line XF498 Homo sapiens IC50 > 30000.0 nM PMID[529383]
NPT146 Cell Line SK-OV-3 Homo sapiens IC50 > 30000.0 nM PMID[529383]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC203351 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9485 High Similarity NPC470991
0.9143 High Similarity NPC27159
0.9118 High Similarity NPC470990
0.8993 High Similarity NPC4796
0.8958 High Similarity NPC474903
0.8947 High Similarity NPC281020
0.8939 High Similarity NPC173608
0.8936 High Similarity NPC470811
0.8936 High Similarity NPC106920
0.8936 High Similarity NPC477696
0.8936 High Similarity NPC273657
0.8936 High Similarity NPC477697
0.8912 High Similarity NPC281477
0.8851 High Similarity NPC16082
0.8851 High Similarity NPC82592
0.8849 High Similarity NPC125417
0.8849 High Similarity NPC25305
0.8849 High Similarity NPC95679
0.8849 High Similarity NPC110899
0.8849 High Similarity NPC112068
0.8832 High Similarity NPC129889
0.8832 High Similarity NPC307006
0.8828 High Similarity NPC125570
0.875 High Similarity NPC142985
0.875 High Similarity NPC195292
0.8733 High Similarity NPC84935
0.8733 High Similarity NPC190020
0.8733 High Similarity NPC77679
0.8725 High Similarity NPC79998
0.8725 High Similarity NPC199926
0.8716 High Similarity NPC473236
0.8707 High Similarity NPC96501
0.8705 High Similarity NPC208760
0.869 High Similarity NPC138978
0.8686 High Similarity NPC469480
0.8667 High Similarity NPC150227
0.8658 High Similarity NPC136757
0.8658 High Similarity NPC287504
0.8658 High Similarity NPC25127
0.8649 High Similarity NPC477699
0.8643 High Similarity NPC209229
0.8636 High Similarity NPC49341
0.8633 High Similarity NPC155098
0.8611 High Similarity NPC239608
0.8611 High Similarity NPC46161
0.8592 High Similarity NPC147379
0.8571 High Similarity NPC274613
0.8571 High Similarity NPC668
0.8571 High Similarity NPC474965
0.8571 High Similarity NPC293757
0.8571 High Similarity NPC113295
0.8571 High Similarity NPC216223
0.8571 High Similarity NPC174512
0.8571 High Similarity NPC477695
0.8571 High Similarity NPC145569
0.8562 High Similarity NPC103201
0.8562 High Similarity NPC473106
0.8552 High Similarity NPC223185
0.8552 High Similarity NPC210425
0.8552 High Similarity NPC277426
0.8552 High Similarity NPC280404
0.8552 High Similarity NPC86373
0.8543 High Similarity NPC469474
0.8543 High Similarity NPC227062
0.8542 High Similarity NPC299154
0.854 High Similarity NPC48315
0.854 High Similarity NPC153547
0.8533 High Similarity NPC197188
0.8533 High Similarity NPC43872
0.8533 High Similarity NPC291510
0.8533 High Similarity NPC116850
0.8533 High Similarity NPC238672
0.8533 High Similarity NPC144801
0.8531 High Similarity NPC100675
0.8531 High Similarity NPC50823
0.8529 High Similarity NPC12022
0.8529 High Similarity NPC20404
0.8529 High Similarity NPC20287
0.8529 High Similarity NPC293641
0.8523 High Similarity NPC75695
0.8523 High Similarity NPC151425
0.8523 High Similarity NPC204350
0.8519 High Similarity NPC280767
0.8511 High Similarity NPC156892
0.8507 High Similarity NPC165375
0.8507 High Similarity NPC220598
0.8506 High Similarity NPC76687
0.85 High Similarity NPC237330
0.8497 Intermediate Similarity NPC292415
0.8496 Intermediate Similarity NPC194416
0.8496 Intermediate Similarity NPC177291
0.8483 Intermediate Similarity NPC469542
0.8483 Intermediate Similarity NPC51106
0.8477 Intermediate Similarity NPC38898
0.8477 Intermediate Similarity NPC20541
0.8472 Intermediate Similarity NPC31751
0.8472 Intermediate Similarity NPC67650
0.8472 Intermediate Similarity NPC253722
0.8472 Intermediate Similarity NPC1704
0.8472 Intermediate Similarity NPC253481
0.8467 Intermediate Similarity NPC289968
0.8467 Intermediate Similarity NPC109275
0.8467 Intermediate Similarity NPC472912
0.8467 Intermediate Similarity NPC167903
0.8467 Intermediate Similarity NPC65591
0.8467 Intermediate Similarity NPC260979
0.8467 Intermediate Similarity NPC199773
0.8467 Intermediate Similarity NPC178574
0.8467 Intermediate Similarity NPC278308
0.8462 Intermediate Similarity NPC471819
0.8456 Intermediate Similarity NPC477700
0.8456 Intermediate Similarity NPC472279
0.8456 Intermediate Similarity NPC76451
0.8451 Intermediate Similarity NPC135837
0.8446 Intermediate Similarity NPC477698
0.8446 Intermediate Similarity NPC194653
0.8446 Intermediate Similarity NPC203747
0.8446 Intermediate Similarity NPC80710
0.8446 Intermediate Similarity NPC139364
0.8446 Intermediate Similarity NPC254702
0.8442 Intermediate Similarity NPC349525
0.844 Intermediate Similarity NPC182496
0.844 Intermediate Similarity NPC180905
0.844 Intermediate Similarity NPC72796
0.844 Intermediate Similarity NPC44245
0.844 Intermediate Similarity NPC211386
0.844 Intermediate Similarity NPC18646
0.8435 Intermediate Similarity NPC208507
0.8435 Intermediate Similarity NPC30720
0.8435 Intermediate Similarity NPC472333
0.8429 Intermediate Similarity NPC159418
0.8429 Intermediate Similarity NPC1321
0.8429 Intermediate Similarity NPC156124
0.8429 Intermediate Similarity NPC288743
0.8429 Intermediate Similarity NPC304929
0.8429 Intermediate Similarity NPC283823
0.8425 Intermediate Similarity NPC207732
0.8425 Intermediate Similarity NPC469683
0.8421 Intermediate Similarity NPC54928
0.8421 Intermediate Similarity NPC165483
0.8417 Intermediate Similarity NPC264145
0.8417 Intermediate Similarity NPC474017
0.8414 Intermediate Similarity NPC474385
0.8411 Intermediate Similarity NPC469550
0.8403 Intermediate Similarity NPC19158
0.84 Intermediate Similarity NPC95498
0.84 Intermediate Similarity NPC200773
0.84 Intermediate Similarity NPC246566
0.84 Intermediate Similarity NPC215921
0.84 Intermediate Similarity NPC256406
0.84 Intermediate Similarity NPC476434
0.84 Intermediate Similarity NPC240768
0.84 Intermediate Similarity NPC70016
0.84 Intermediate Similarity NPC56184
0.8394 Intermediate Similarity NPC127587
0.8392 Intermediate Similarity NPC325625
0.8389 Intermediate Similarity NPC473091
0.8389 Intermediate Similarity NPC264550
0.8389 Intermediate Similarity NPC69430
0.8389 Intermediate Similarity NPC200060
0.8389 Intermediate Similarity NPC333691
0.8389 Intermediate Similarity NPC142876
0.8389 Intermediate Similarity NPC195763
0.8389 Intermediate Similarity NPC270160
0.8389 Intermediate Similarity NPC237440
0.8389 Intermediate Similarity NPC139293
0.8389 Intermediate Similarity NPC264289
0.8389 Intermediate Similarity NPC40290
0.8382 Intermediate Similarity NPC58279
0.8382 Intermediate Similarity NPC300326
0.8378 Intermediate Similarity NPC125449
0.8378 Intermediate Similarity NPC188074
0.8378 Intermediate Similarity NPC210320
0.8377 Intermediate Similarity NPC24627
0.8369 Intermediate Similarity NPC5310
0.8369 Intermediate Similarity NPC68779
0.8369 Intermediate Similarity NPC300776
0.8369 Intermediate Similarity NPC176814
0.8369 Intermediate Similarity NPC4982
0.8367 Intermediate Similarity NPC213482
0.8367 Intermediate Similarity NPC474799
0.8367 Intermediate Similarity NPC157133
0.8367 Intermediate Similarity NPC472560
0.8367 Intermediate Similarity NPC287275
0.8366 Intermediate Similarity NPC469584
0.8366 Intermediate Similarity NPC129684
0.8366 Intermediate Similarity NPC108456
0.8366 Intermediate Similarity NPC179732
0.8366 Intermediate Similarity NPC222689
0.8366 Intermediate Similarity NPC299520
0.8366 Intermediate Similarity NPC35598
0.8357 Intermediate Similarity NPC50763
0.8357 Intermediate Similarity NPC111888
0.8356 Intermediate Similarity NPC119663
0.8356 Intermediate Similarity NPC472006
0.8356 Intermediate Similarity NPC471417
0.8356 Intermediate Similarity NPC287722
0.8356 Intermediate Similarity NPC469615
0.8356 Intermediate Similarity NPC254659
0.8355 Intermediate Similarity NPC476642

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC203351 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8429 Intermediate Similarity NPD230 Phase 1
0.8333 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8273 Intermediate Similarity NPD3027 Phase 3
0.8224 Intermediate Similarity NPD1934 Approved
0.8105 Intermediate Similarity NPD37 Approved
0.8077 Intermediate Similarity NPD6234 Discontinued
0.8065 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8065 Intermediate Similarity NPD3882 Suspended
0.8052 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8052 Intermediate Similarity NPD2801 Approved
0.8038 Intermediate Similarity NPD6232 Discontinued
0.8 Intermediate Similarity NPD3817 Phase 2
0.8 Intermediate Similarity NPD7473 Discontinued
0.7975 Intermediate Similarity NPD7199 Phase 2
0.7949 Intermediate Similarity NPD4965 Approved
0.7949 Intermediate Similarity NPD4967 Phase 2
0.7949 Intermediate Similarity NPD4966 Approved
0.7937 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7937 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7937 Intermediate Similarity NPD6166 Phase 2
0.7933 Intermediate Similarity NPD1511 Approved
0.7881 Intermediate Similarity NPD2532 Approved
0.7881 Intermediate Similarity NPD2534 Approved
0.7881 Intermediate Similarity NPD2533 Approved
0.7872 Intermediate Similarity NPD9494 Approved
0.7853 Intermediate Similarity NPD7074 Phase 3
0.784 Intermediate Similarity NPD7228 Approved
0.784 Intermediate Similarity NPD3818 Discontinued
0.7832 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7829 Intermediate Similarity NPD1512 Approved
0.7821 Intermediate Similarity NPD1465 Phase 2
0.7815 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7791 Intermediate Similarity NPD7054 Approved
0.7778 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.777 Intermediate Similarity NPD1608 Approved
0.777 Intermediate Similarity NPD9269 Phase 2
0.7764 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7755 Intermediate Similarity NPD1510 Phase 2
0.7744 Intermediate Similarity NPD7472 Approved
0.7733 Intermediate Similarity NPD4628 Phase 3
0.7724 Intermediate Similarity NPD1240 Approved
0.7724 Intermediate Similarity NPD1613 Approved
0.7724 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7711 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD6799 Approved
0.7683 Intermediate Similarity NPD5844 Phase 1
0.7673 Intermediate Similarity NPD7075 Discontinued
0.7669 Intermediate Similarity NPD228 Approved
0.7628 Intermediate Similarity NPD4380 Phase 2
0.7628 Intermediate Similarity NPD6599 Discontinued
0.7622 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD1607 Approved
0.7603 Intermediate Similarity NPD943 Approved
0.7595 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7595 Intermediate Similarity NPD7819 Suspended
0.759 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.759 Intermediate Similarity NPD6797 Phase 2
0.7569 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7566 Intermediate Similarity NPD6190 Approved
0.7554 Intermediate Similarity NPD17 Approved
0.7551 Intermediate Similarity NPD447 Suspended
0.7545 Intermediate Similarity NPD7251 Discontinued
0.7533 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7533 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD6801 Discontinued
0.7516 Intermediate Similarity NPD919 Approved
0.75 Intermediate Similarity NPD7808 Phase 3
0.75 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD4110 Phase 3
0.75 Intermediate Similarity NPD1653 Approved
0.75 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD1549 Phase 2
0.7482 Intermediate Similarity NPD9268 Approved
0.7469 Intermediate Similarity NPD5494 Approved
0.7467 Intermediate Similarity NPD6099 Approved
0.7467 Intermediate Similarity NPD2935 Discontinued
0.7467 Intermediate Similarity NPD6100 Approved
0.7465 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7453 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7438 Intermediate Similarity NPD5353 Approved
0.7419 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7419 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7413 Intermediate Similarity NPD1283 Approved
0.7412 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.741 Intermediate Similarity NPD9545 Approved
0.74 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7358 Intermediate Similarity NPD7411 Suspended
0.7351 Intermediate Similarity NPD1551 Phase 2
0.7337 Intermediate Similarity NPD7685 Pre-registration
0.7337 Intermediate Similarity NPD7240 Approved
0.7333 Intermediate Similarity NPD5242 Approved
0.7329 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7315 Intermediate Similarity NPD6355 Discontinued
0.731 Intermediate Similarity NPD5647 Approved
0.7308 Intermediate Similarity NPD3688 Clinical (unspecified phase)
0.7308 Intermediate Similarity NPD3146 Approved
0.7299 Intermediate Similarity NPD5283 Phase 1
0.7285 Intermediate Similarity NPD7033 Discontinued
0.7284 Intermediate Similarity NPD7768 Phase 2
0.7273 Intermediate Similarity NPD3750 Approved
0.7267 Intermediate Similarity NPD6651 Approved
0.7267 Intermediate Similarity NPD6653 Approved
0.7248 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7248 Intermediate Similarity NPD3620 Phase 2
0.7248 Intermediate Similarity NPD4060 Phase 1
0.7237 Intermediate Similarity NPD2796 Approved
0.7222 Intermediate Similarity NPD2982 Phase 2
0.7222 Intermediate Similarity NPD2983 Phase 2
0.7222 Intermediate Similarity NPD5402 Approved
0.7215 Intermediate Similarity NPD5403 Approved
0.7211 Intermediate Similarity NPD4908 Phase 1
0.7203 Intermediate Similarity NPD422 Phase 1
0.7203 Intermediate Similarity NPD1281 Approved
0.7203 Intermediate Similarity NPD3705 Approved
0.7203 Intermediate Similarity NPD1610 Phase 2
0.7192 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7183 Intermediate Similarity NPD1778 Approved
0.7169 Intermediate Similarity NPD5710 Approved
0.7169 Intermediate Similarity NPD5711 Approved
0.7161 Intermediate Similarity NPD8166 Discontinued
0.716 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7153 Intermediate Similarity NPD2981 Phase 2
0.7143 Intermediate Similarity NPD3018 Phase 2
0.7135 Intermediate Similarity NPD6559 Discontinued
0.7133 Intermediate Similarity NPD826 Approved
0.7133 Intermediate Similarity NPD825 Approved
0.7126 Intermediate Similarity NPD3926 Phase 2
0.7124 Intermediate Similarity NPD2438 Suspended
0.7124 Intermediate Similarity NPD9570 Approved
0.7114 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7114 Intermediate Similarity NPD6798 Discontinued
0.7114 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7113 Intermediate Similarity NPD1357 Approved
0.7108 Intermediate Similarity NPD1247 Approved
0.7108 Intermediate Similarity NPD6959 Discontinued
0.7103 Intermediate Similarity NPD4749 Approved
0.7097 Intermediate Similarity NPD2800 Approved
0.7097 Intermediate Similarity NPD1243 Approved
0.7097 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD5401 Approved
0.7089 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7078 Intermediate Similarity NPD6002 Phase 3
0.7078 Intermediate Similarity NPD6005 Phase 3
0.7078 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7078 Intermediate Similarity NPD6004 Phase 3
0.7078 Intermediate Similarity NPD7266 Discontinued
0.7078 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7067 Intermediate Similarity NPD6233 Phase 2
0.7066 Intermediate Similarity NPD7229 Phase 3
0.7066 Intermediate Similarity NPD3787 Discontinued
0.7047 Intermediate Similarity NPD7095 Approved
0.7045 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD6386 Approved
0.7037 Intermediate Similarity NPD6385 Approved
0.7034 Intermediate Similarity NPD9717 Approved
0.703 Intermediate Similarity NPD3749 Approved
0.7025 Intermediate Similarity NPD4357 Discontinued
0.7021 Intermediate Similarity NPD9493 Approved
0.702 Intermediate Similarity NPD2979 Phase 3
0.7017 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7007 Intermediate Similarity NPD3021 Approved
0.7007 Intermediate Similarity NPD2797 Approved
0.7007 Intermediate Similarity NPD3022 Approved
0.7006 Intermediate Similarity NPD8127 Discontinued
0.7006 Intermediate Similarity NPD2219 Phase 1
0.7 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD920 Approved
0.7 Intermediate Similarity NPD3268 Approved
0.6993 Remote Similarity NPD6111 Discontinued
0.6987 Remote Similarity NPD1652 Phase 2
0.6974 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6974 Remote Similarity NPD5124 Phase 1
0.6972 Remote Similarity NPD5536 Phase 2
0.6962 Remote Similarity NPD643 Clinical (unspecified phase)
0.6959 Remote Similarity NPD257 Approved
0.6959 Remote Similarity NPD258 Approved
0.6957 Remote Similarity NPD3686 Approved
0.6957 Remote Similarity NPD3687 Approved
0.6954 Remote Similarity NPD4062 Phase 3
0.695 Remote Similarity NPD7157 Approved
0.6948 Remote Similarity NPD2799 Discontinued
0.6948 Remote Similarity NPD3748 Approved
0.6948 Remote Similarity NPD1509 Clinical (unspecified phase)
0.6944 Remote Similarity NPD4626 Approved
0.6934 Remote Similarity NPD2684 Approved
0.6933 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6923 Remote Similarity NPD1548 Phase 1
0.6918 Remote Similarity NPD1481 Phase 2
0.6914 Remote Similarity NPD4005 Discontinued
0.6914 Remote Similarity NPD7458 Discontinued
0.6901 Remote Similarity NPD3751 Discontinued
0.6897 Remote Similarity NPD3847 Discontinued
0.6892 Remote Similarity NPD1203 Approved
0.6887 Remote Similarity NPD411 Approved
0.6887 Remote Similarity NPD1296 Phase 2
0.6879 Remote Similarity NPD5953 Discontinued
0.6879 Remote Similarity NPD2654 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data